NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Global Market Update: 2 March

The stock market experienced a significant downturn on 2 March, driven by the escalation of the war in West Asia. This geopolitical development thrust geopolitical risk back to the forefront of global finance, resulting in a substantial decline in market value.

Key Statistics:

  • Market value erased: ₹6.5 trillion
  • Affected companies: BSE-listed
  • India VIX increase: 23.5%, the largest single-day climb in nearly 11 months
  • Market sentiment: investor anxiety on the rise

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The surge in India VIX, a fear gauge, reflects the growing concern among investors. This increase in volatility is likely to have a lasting impact on the market, as investors reassess their risk tolerance and adjust their portfolios accordingly.

Investor Takeaway

Investors should be cautious and consider diversifying their portfolios in response to rising geopolitical risk.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.